Abbott Laboratories (M) Sdn Bhd

Abbott is a global healthcare company that develops, manufactures and markets a broad portfolio across diagnostics, medical devices, nutritionals and established pharmaceuticals. Its primary activities include clinical and point-of-care diagnostics, cardiovascular and neuromodulation devices, diabetes care (notably the FreeStyle Libre continuous glucose monitoring systems), and infant and adult nutrition products. Abbott serves hospitals, clinical laboratories, physicians, retail pharmacies and direct-to-consumer markets, targeting both healthcare systems and individual patients across acute and chronic care settings. Founded in 1888 and headquartered in Abbott Park, Illinois, Abbott operates in more than 160 countries and employs well over 100,000 people worldwide, generating annual revenue in the tens of billions of dollars; it is publicly traded on the New York Stock Exchange (ticker: ABT). The company is a major player in diagnostics, diabetes care and medical devices, with distinguishing milestones that include the commercial success of FreeStyle Libre, rapid COVID-19 diagnostics deployment and strategic acquisitions such as St. Jude Medical and Alere in 2017. Abbott’s competitive strengths include a diversified portfolio, global manufacturing and distribution, and deep relationships with healthcare providers and payers. The company advances growth through R&D, targeted acquisitions and incremental product and regulatory approvals, maintaining a strong global footprint and ongoing expansions in diabetes monitoring and in vitro diagnostics.